We recently proposed that the impact of involuntary movements on...doi:10.1016/j.parkreldis.2017.11.039Goubault, E.Nguyen, H.P.Bogard, S.Faucher, G.Duval, C.Parkinsonism & Related Disorders
Background There is a need for an objective method of symptom assessment in Parkinson's disease (PD) to enable better treatment decisions and to aid evaluation of new treatments. Current assessment methods; patient-completed symptom diaries and clinical rating scales, have limitations. Accelerometers ...
A thorough understanding of the relationship between cognitive test performance and symptoms of depression, anxiety, or post-traumatic stress disorder (PTS
DHA effects in Parkinson disease depression. Basal Ganglia. 2014;4(2):61-66. doi:10.1016/j.baga.2014.03.004Google ScholarCrossref 53. Widenhorn-Müller K, Schwanda S, Scholz E, Spitzer M, Bode H. Effect of supplementation with long-chain ω-3 polyunsaturated fatty ...
Additionally, patients and controls with neuro-immune, autoimmune, and immune-related conditions, encompassing Parkinson's disease, Alzheimer's disease, multiple sclerosis, stroke, psoriasis, chronic kidney disease, Chronic obstructive pulmonary disease (COPD), and scleroderma were not eligible to ...
doi:10.1007/s00384-013-1824-4 PubMedGoogle ScholarCrossref 39. Dharwadkar P, Greenan G, Singal AG, Murphy CC. Is colorectal cancer in patients younger than 50 years of age the same disease as in older patients? Clin Gastroenterol Hepatol. 2021;19(1):192-194.e3...
In 2003, Alberts rode a tandem bike across the state of Iowa with a Parkinson's patient from Atlanta, Ga., named Cathy, who said how great she felt when riding. She told him, “It doesn’t feel like I have Parkinson’s disease.’” ...
We excluded controls and patients with pre-existing medical conditions, such as type 1 diabetes, and liver, kidney, and cardiovascular disease and cancer, and pre-existing neuro-psychiatric disease including dementia, Parkinson's disorder, multiple sclerosis, and axis-I psychiatric disorders including ...